Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02701218
Other study ID # ENT-2558-03601
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 2016
Est. completion date December 2019

Study information

Verified date July 2019
Source Chiang Mai University
Contact Suwicha I Kaewsiri, MD
Phone 66-816802036
Email suwicha.kaewsiri@cmu.ac.th
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Unilateral posterior canal benign paroxysmal positional vertigo (BPPV) cases will be randomized to treat with single or multiple cycles of canalith repositioning procedure.The treatment outcomes will be assessed at 7th and 28th days.


Description:

Patients present with brief episodes of vertigo will be evaluated by Dix-Hallpike test. Cases with positive Dix-Hallpike test, unilateral, posterior canal, will be randomized with block of four. Either single or multiple cycles of canalith repositioning procedure will be performed. Four treatment outcomes will be blindly assessed at 7 and 28 days.


Recruitment information / eligibility

Status Recruiting
Enrollment 114
Est. completion date December 2019
Est. primary completion date March 2019
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria:

1. Recurrent episodes of vertigo

2. 15 years of age or older

3. Positive Dix-Hallpike test: unilateral, posterior canal

Exclusion Criteria:

1. Received vestibular suppressant within 6 hours

2. With other diseases or conditions cause of vertigo or central nervous system disease

3. With diseases or conditions contraindicate for Dix-Hallpike test or CRP eg: cervical spine disease, back/ neck stiffness, retinal detachment

4. Positive Dix-Hallpike test: bilateral, other canals

5. Complications from CRP eg: nausea, vomiting, canalith jam

6. Cannot read the questionaire

Study Design


Related Conditions & MeSH terms

  • Benign Paroxysmal Positional Vertigo
  • Benign Paroxysmal Positional Vertigo (BPPV)
  • Dizziness
  • Vertigo

Intervention

Procedure:
Canalith repositioning procedure
Canalith repositioning procedure; single or multiple cycles

Locations

Country Name City State
Thailand Department of Otolaryngology Faculty of Medicine, Chiang Mai University 110 Intawaroros Road, Sriphum Chiang Mai

Sponsors (1)

Lead Sponsor Collaborator
Chiang Mai University

Country where clinical trial is conducted

Thailand, 

References & Publications (1)

Bhattacharyya N, Baugh RF, Orvidas L, Barrs D, Bronston LJ, Cass S, Chalian AA, Desmond AL, Earll JM, Fife TD, Fuller DC, Judge JO, Mann NR, Rosenfeld RM, Schuring LT, Steiner RW, Whitney SL, Haidari J; American Academy of Otolaryngology-Head and Neck Sur — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Dix-Hallpike test (DHT) percentage of negative DHT between single and multiple cycles At 7th day
Secondary Dizziness handicap inventory (DHI) total score in the questionaire compare to the first visit at 7th between single and multiple cycles
Secondary Dizziness handicap inventory (DHI) total score in the questionaire compare to the first visit at 28th day between single and multiple cycles
Secondary Subjective symptoms Asking the patient's symptom: Improve, same, worse Improvement of the symptoms compare to the first visit at 7th day between single and multiple cycles
Secondary Subjective symptoms Asking the patient's symptom: Improve, same, worse Improvement of the symptoms compare to the first visit at 28th day between single and multiple cycles
Secondary Loss of balance 5 levels Level 1: Able to continue daily activities without any helps. Level 2: Able to continue daily activities without any helps except complicated activities such as riding a bicycle, walking on counterpoise or scaffolding.
Level 3: Not able to continue daily activities without help excepts simple activities such as self-care, housework, walking, or being a passenger in a vehicle Level 4: Not able to continue daily activities alone without help except self-care Level 5 Not able to continue daily activities alone without help except self-care without ambulation. Need to stay only in a house or a living place.
(From: The Royal college of Otolaryngologists head and neck surgeons of Thailand, and social security office of thailand)
compare to the first visit at 7th between single and multiple cycles
Secondary Loss of balance 5 levels Level 1: Able to continue daily activities without any helps. Level 2: Able to continue daily activities without any helps except complicated activities such as riding a bicycle, walking on counterpoise or scaffolding.
Level 3: Not able to continue daily activities without help excepts simple activities such as self-care, housework, walking, or being a passenger in a vehicle Level 4: Not able to continue daily activities alone without help except self-care Level 5 Not able to continue daily activities alone without help except self-care without ambulation. Need to stay only in a house or a living place.
(From: The Royal college of Otolaryngologists head and neck surgeons of Thailand, and social security office of thailand)
compare to the first visit at 28th day between single and multiple cycles
Secondary Dix-Hallpike test (DHT) percentage of negative DHT between single and multiple cycles At 28th day
See also
  Status Clinical Trial Phase
Recruiting NCT01822002 - Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo N/A
Completed NCT04849182 - Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV N/A
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Recruiting NCT05984901 - The CAVA Multicentre Dizziness Trial N/A